Inventor · disambiguated record
Philippe Erbs
Also filed as: ERBS PHILIPPE
17 granted patents·3 pending applications·84 citations·filing 1999–2017
92Inventor score
Top patents by PatentIndex Score
20 records- 0191US7572438B2Mutant having uracil phosphoribosyl transferase activityTRANSGENE SA·Filed 2005·Granted Aug 11, 2009·12 cites·7 claims
- 0289US8778328B2Poxviral oncolytic vectorsERBS PHILIPPE·Filed 2008·Granted Jul 15, 2014·19 cites·29 claims
- 0387US9180150B2Poxviral oncolytic vectorsERBS PHILIPPE·Filed 2008·Granted Nov 10, 2015·16 cites·6 claims
- 0482US9687515B2Poxviral oncolytic vectorsTRANSGENE SA·Filed 2014·Granted Jun 27, 2017·3 cites·14 claims
- 0574US8211421B2Mutant having uracil phosphoribosyl transferase activityERBS PHILIPPE·Filed 2009·Granted Jul 3, 2012·0 cites·7 claims
- 0673US8513018B2Immortalized avian cell linesERBS PHILIPPE·Filed 2012·Granted Aug 20, 2013·1 cites·6 claims
- 0773US8357531B2Immortalized avian cell linesTRANSGENE SA·Filed 2010·Granted Jan 22, 2013·1 cites·6 claims
- 0872US6596533B1Mutant having uracil phosphoribosyl transferase activityTRANSGENE SA·Filed 1999·Granted Jul 22, 2003·23 cites·12 claims
- 0971US7049117B2Mutant possessing uracil phosphoribosyl transferase activityTRANSGENE SA·Filed 2003·Granted May 23, 2006·4 cites·9 claims
- 1069US9884080B2Poxviral oncolytic vectorsTRANSGENE SA·Filed 2013·Granted Feb 6, 2018·1 cites·6 claims
- 1169US7790445B2Polypeptide having an improved cytosine deaminase activityTRANSGENE SA·Filed 2004·Granted Sep 7, 2010·3 cites·28 claims
- 1264US7348014B2Poxvirus with targeted infection specificityTRANSGENE SA·Filed 2004·Granted Mar 25, 2008·1 cites·19 claims
- 1361US8361788B2Immortalized avian cell lines comprising E1A nucleic acid sequencesTRANSGENE SA·Filed 2008·Granted Jan 29, 2013·0 cites·13 claims
- 1455US9024003B2Avian telomerase reverse transcriptaseERBS PHILIPPE·Filed 2007·Granted May 5, 2015·0 cites·15 claims
- 1553US8226954B2Polypeptide having an improved cytosine deaminase activityERBS PHILIPPE·Filed 2010·Granted Jul 24, 2012·0 cites·4 claims
- 1652US2013039891A1Poxviral oncolytic vectorsTRANSGENE SA·Filed 2012·Application pending·0 cites
- 1751US8257692B2Polypeptide having an improved cytosine deaminase activityERBS PHILIPPE·Filed 2010·Granted Sep 4, 2012·0 cites·2 claims
- 1850US8470591B2Kit of parts designed for implementing an antitumoral or antiviral treatment in a mammalERBS PHILIPPE·Filed 2005·Granted Jun 25, 2013·0 cites·18 claims
- 1940US2019330655A1Oncolytic viruses and therapeutic moleculesTRANSGENE SA·Filed 2017·Application pending·0 cites
- 2039US2013095557A1Immortalized avian cell linesERBS PHILIPPE·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Philippe Erbs files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →